| This week's sponsor is Premier Research. | |  | Opportunity Knocks: Seizing the Promise of Orphan Drugs
Orphan drug developers enjoy more favorable regulatory conditions today than ever. Read our white paper for tips on maximizing this opportunity. Premier Research. It's what we do. Best. |
Today's Rundown Featured Story | | | Friday, April 6, 2018 The combination of Incyte’s epacadostat and Merck & Co.’s Keytruda was supposed to pose a major threat to rival Bristol-Myers Squibb’s melanoma franchise—but the data tell a different story. |
|
|
| This week's sponsor is STEMCELL Technologies. | |  | |
Top Stories Friday, April 6, 2018 Unity Biotechnology has filed for an $85 million IPO. Hitting the target would bring the preclinical anti-aging startup’s fundraising haul up toward $300 million and set it up to move two assets into the clinic. Friday, April 6, 2018 Novo Nordisk has moved into sickle cell disease through a licensing deal with EpiDestiny. The $400 million deal gives Novo worldwide rights to an epigenetic treatment of the disease that is closing in on the start of a phase 2 trial. Monday, April 2, 2018 How we measure outcomes will evolve from applying one solution to finding an empirical basis for a highly customized application of all of them. Personalized medicine needs a more personalized approach to measurement. Read more. Friday, April 6, 2018 Injectable drugs used to treat inflammatory arthritis are usually cleared quickly from joints, limiting their effectiveness. A PureTech startup is developing an immune-responsive hydrogel system that releases a corticosteroid into arthritic joints based on their level of inflammation. Thursday, April 5, 2018 In this week's EuroBiotech Report, Sofinnova Partners raised €275 million on later-stage bets, while ITBMed raised $67 million. Meantime, Nordic Nanovector delayed a pivotal lymphoma trial readout. Friday, April 6, 2018 A long list of biopharma products from China are proposed targets for additional U.S. tariffs, analysts now think the Takeda-Shire deal is "more likely than not," China puts forward a policy package that favors generics over brands and more. Friday, April 6, 2018 Celgene COO Scott Smith steps down after recent setbacks, former Kite leaders Belldegrun and Chang are back at a new CAR-T shop, former GSK Dermatology executive Rubenstein is among several C-suite hires at Dermavant, plus more hirings, firings and retirings throughout the industry. | This week's sponsor is Sensors Expo. | |  | |
Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Sponsored by: USDM Life Sciences What are the biggest trends in life sciences this year? Sponsored by: Halo Pharma Why does confidence matter when outsourcing Fixed-Dose Combination products? Download Halo Pharma’s white paper on the importance of product design, technology, and analyticals tools for FDC. Sponsored by: WCG Small biopharma companies are conducting almost 50% of the clinical trials in the US today, yet they face unique challenges that large pharma do not. In this paper, we explore some of those challenges, and solutions that can reduce the pressure on small biopharma teams and timelines. Sponsored by: Veeva Systems Explore a new model for events management, and learn how to deliver more value. Presented by: Patheon, part of Thermo Fisher Scientific Patheon's Stephen Lam reviews the formidable challenges and decisions facing biopharma manufacturing executives. Watch as he shares unique insights and perspectives and demonstrates how there is really no one-size-fits-all solution in biomanufacturing, regardless of company size. Presented by: Charles River How do you get your oncology therapy to the clinic? The path isn’t always clear. In vitro, ex vivo, xenograft, syngeneic, PDX, humanized models, immunology considerations, safety regulations – which do you need to plan for and when? Sponsored by: DocuSign Life science companies are experiencing a significant transformation in how they bring new products to market. Sponsored by: Reprints Desk The competitive landscape in medical device R&D is tough. And simply investing in R&D is no guarantee for profitability. So how do you accelerate time-to-market? Sponsored by: WCG Selecting the right sites to conduct your clinical trials will determine the success or failure of meeting your enrollment goals. Presented by: Covance Global clinical trials are the trend and gaining in popularity, but running a global trial is not a straightforward process. This white paper explores some of the challenges associated with global clinical trials and considerations for ensuring that the collected data comply with the trial's overall objectives. Presented by: Charles River Join us as we discuss how Charles River Celsis® helped Labor L+S AG validate a 7-day membrane filtration sterility test using existing protocols. Presented by: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented by: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented by: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored by: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Sensors Expo & Conference Conference & Expo: June 26-28, 2018 | Pre-Conference Symposia: June 25, 2018 | San Jose, CA IRT Europe – Interactive Response Technologies in Clinical Trials April 10th-11th, 2018 | Brussels, Belgium Field Service USA 2018 April 17-April 20, 2018 | JW Marriott Palm Desert Resort & Spa, CA
Drug Development Immersion April 25-26, 2018 | New York City Biotech for the Non-Scientist May 2-3, 2018 | San Diego, CA MIXiii-Biomed 2018 May 15-17, 2018 | Tel-Aviv, Israel Drug Development Immersion May 17-18, 2018 | Boston, MA BIO International Convention June 4-7, 2018 | Boston, MA
BioBasics: Biotech for the Non-Scientist June 13 - 14, 2018 | Toronto, Canada BioBasics: Biotech for the Non-Scientist June 13 - 14, 2018 | West Windsor, NJ Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA | Register and start preparing Today! | 
